Copyright
©The Author(s) 2021.
World J Stem Cells. Aug 26, 2021; 13(8): 1134-1150
Published online Aug 26, 2021. doi: 10.4252/wjsc.v13.i8.1134
Published online Aug 26, 2021. doi: 10.4252/wjsc.v13.i8.1134
Ref. | Population studied/study design | Diagnosis criteria | Sample | Technique | Metabolite with increased levels | Metabolite with decreased levels | |||||||
Menzies et al[23], 2020 | 20 FMS (20 F, 0 M). 20 HC (20 F, 0 M). Mean age in both groups 41.9 yr. Age range and medium age NA | ACR 1990 criteria | Plasma | LC-MS | Amino acid metabolism | Taurine | P < 0.001 | Energy metabolism | 2-hydroxyglutarate | P < 0.001 | |||
Methionine sulfoxide | |||||||||||||
Anthranilate | |||||||||||||
Lipid metabolism | Lysophosphocholines (16:0) | ||||||||||||
Lysophosphocholines (18:0) | |||||||||||||
Lysophosphocholines (20:4) | P = 0.001 | Alpha-ketoglutaric acid | NA | ||||||||||
Lysophosphocholines (22:6) | |||||||||||||
Lysophosphocholines (18:1) | P = 0.003 | ||||||||||||
Lysophosphocholines (16:1) | P = 0.007 | ||||||||||||
Caboni et al[24], 2014 | 22 FMS (22 F, 0 M). Age range 27-72 yr. Mean age 52 yr. 21 HC (21 F, 0 M). Age range 27-67 yr. Mean age 50 yr. Median age NA | ACR criteria | Plasma | LC-Q-TOF/MS | 1-hexadecanoyl-sn-glycero-3-phosphocholine [PC (16:0)] | NA | NA | ||||||
1-tetradecanoyl-sn-glycero-3-phosphocholine [PC (14:0)] | |||||||||||||
Clos-Garcia et al[25], 2019 | 105 FMS (73 F, 32 M). 54 HC (26 F, 28 M). Age range and mean and medium age NA | ACR 2010 criteria | Serum | UPLC-MS | Ornithine | NA | Platelet activating factor (PAF-16) | NA | |||||
L-arginine | |||||||||||||
Nε-Methyl-L-lysine | |||||||||||||
L-glutamate | |||||||||||||
Asymmetric dimethylarginine (ADMA) | |||||||||||||
l-threonine/DL-homoserin | |||||||||||||
L-glutamine | |||||||||||||
Hackshaw et al[26], 2013 | 10 FMS (9 F, 1 M). Mean age 50 yr. 10 OA (7 F, 3 M). Mean age 65 yr. 10 RA (9 F, 1 M). Mean age 60 yr. Age range and median age NA | ARC criteria | Blood | UHPLC/MS/MS | Trans-urocanate | NA | NA | NA | |||||
Asparagine | |||||||||||||
Heme | |||||||||||||
Cysteine–glutathione disulfide | |||||||||||||
Glucose | |||||||||||||
Pyruvate | |||||||||||||
Nicotinamide adenine dinucleotide (NAD+) | |||||||||||||
Malatji et al[27], 2019 | 17 FMS (17 F, 0 M). 62 HC (62 F, 0 M), 11 CF, 10 CO, 41 CN (age range 18-22 yr). Median and mean age: NA | ACR 1990 criteria | Urine | GC-MS | 3-D-Ribohexonic acid | P = 0.0000089 | |||||||
Sorbose | P < 0.00001 | ||||||||||||
Threonic acid | |||||||||||||
Erythropentonic acid | |||||||||||||
2-Keto-1-gluconic acid | |||||||||||||
2-hydroxyglutaric acid | P = 0.000013 | ||||||||||||
Arabinose | P = 0.000017 | ||||||||||||
2-D-3,5-DHPL | P = 0.000019 | ||||||||||||
2,3,4-Trihydroxybutyl-L | P = 0.000021 | ||||||||||||
Phosphoric acid | P = 0.00011 | ||||||||||||
Glutaric acid | |||||||||||||
Oxalic acid | |||||||||||||
Rhamnose | |||||||||||||
Tagatose | P = 0.00024 | ||||||||||||
4-HBA | P = 0.00109 | ||||||||||||
Malic acid | P = 0.024 | ||||||||||||
Malatji et al[28], 2017 | 18 FMS (18 F, 0 M). 41 HC (41 F, 0 M), 11 FR, 10 AM, 20 YHC (age range 18-22 yr). Median and mean age NA | ARC 1990 criteria | Urine | QE-MS | Gut microbiome | Succinic acid | P = 0.0001 | NA | |||||
Lactic acid | P = 0.0044 | ||||||||||||
Hippuric | P = 0.09 | ||||||||||||
Osmolytes | Taurine | P = 0.0007 | |||||||||||
TMAO | P = 0.006 |
- Citation: Monzón-Nomdedeu MB, Morten KJ, Oltra E. Induced pluripotent stem cells as suitable sensors for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome. World J Stem Cells 2021; 13(8): 1134-1150
- URL: https://www.wjgnet.com/1948-0210/full/v13/i8/1134.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i8.1134